ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $9,157,000 | +18.0% | 171,291 | -8.9% | 0.17% | -15.5% |
| Q3 2020 | $7,759,000 | -29.1% | 188,089 | -16.6% | 0.21% | -33.8% |
| Q2 2020 | $10,938,000 | -36.7% | 225,657 | -44.8% | 0.31% | -49.8% |
| Q1 2020 | $17,278,000 | +8.6% | 408,954 | +10.0% | 0.62% | +52.8% |
| Q4 2019 | $15,905,000 | +12.1% | 371,777 | -5.7% | 0.40% | +4.9% |
| Q3 2019 | $14,189,000 | -1.4% | 394,253 | -26.8% | 0.39% | +8.7% |
| Q2 2019 | $14,388,000 | -0.7% | 538,278 | -0.2% | 0.36% | -1.9% |
| Q1 2019 | $14,484,000 | +31.8% | 539,444 | -20.6% | 0.36% | +16.8% |
| Q4 2018 | $10,989,000 | -29.7% | 679,605 | -9.8% | 0.31% | -16.4% |
| Q3 2018 | $15,639,000 | – | 753,314 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |